|
Delayed
Japan Exchange
23:53:56 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 2,349.50 JPY | +0.95% |
|
+0.90% | +12.18% |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| 08-05 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| Market Cap | 4,173B 26.19B 22.7B 21.28B 19.4B 36.5B 2,499B 37.09B 251B 97.81B 1,251B 98.31B 96.18B | P/E 2027 * |
11.5x | P/E 2028 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4,184B 26.26B 22.76B 21.33B 19.45B 36.6B 2,506B 37.19B 251B 98.07B 1,254B 98.57B 96.44B | EV / Sales 2027 * |
1.82x | EV / Sales 2028 * | 1.78x |
| Free-Float |
98.88% | Yield 2027 * |
3.45% | Yield 2028 * | 3.56% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +0.88% | ||
| 1 week | +0.90% | ||
| Current month | +6.63% | ||
| 1 month | +9.41% | ||
| 3 months | -0.82% | ||
| 6 months | -3.43% | ||
| Current year | +12.18% |
| 1 week | 2,297 |  | 2,377 |
| 1 month | 2,110 | | 2,377 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 63 | 2019-05-31 |
| Director/Board Member | 58 | 2023-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | +0.90% | +42.13% | +5.58% | 26.53B | |
| -0.92% | +1.43% | +83.05% | +128.86% | 1,088B | |
| +0.47% | +1.98% | +50.26% | +50.75% | 629B | |
| +0.83% | +2.85% | +24.49% | +64.82% | 440B | |
| -0.88% | -0.66% | +45.09% | +36.64% | 359B | |
| -0.37% | -1.15% | +26.89% | +36.31% | 291B | |
| +0.05% | -1.20% | +2.31% | +6.15% | 245B | |
| +0.40% | +3.21% | +44.42% | +59.17% | 225B | |
| -0.42% | +1.58% | -8.48% | -51.94% | 204B | |
| +1.67% | +5.56% | +14.98% | +72.68% | 168B | |
| Average | +0.17% | +2.40% | +32.51% | +40.90% | 367.57B | |
| Weighted average by Cap. | -0.12% | +1.52% | +46.03% | +65.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,296B 14.41B 12.49B 11.71B 10.67B 20.08B 1,375B 20.41B 138B 53.81B 688B 54.09B 52.92B | 2,107B 13.22B 11.46B 10.74B 9.79B 18.43B 1,262B 18.72B 126B 49.37B 631B 49.63B 48.55B |
| Net income | 349B 2.19B 1.9B 1.78B 1.62B 3.05B 209B 3.1B 20.93B 8.17B 105B 8.21B 8.04B | 325B 2.04B 1.77B 1.66B 1.51B 2.84B 195B 2.89B 19.52B 7.62B 97.46B 7.66B 7.49B |
| Net Debt | 11.12B 69.79M 60.5M 56.71M 51.71M 97.3M 6.66B 98.86M 668M 261M 3.33B 262M 256M | -418B -2.62B -2.27B -2.13B -1.94B -3.65B -250B -3.71B -25.08B -9.79B -125B -9.84B -9.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | JP¥2,349.50 | +0.95% | 2,649,400 |
| 26-08-13 | JP¥2,327.50 | -1.21% | 4,696,600 |
| 26-08-12 | JP¥2,356.00 | -0.30% | 6,164,000 |
| 26-08-10 | JP¥2,363.00 | +1.55% | 6,287,500 |
| 26-08-07 | JP¥2,327.00 | +1.68% | 8,001,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
